Loading...
•
Jun 30, 2023
Utah Medical Q2 2023 Earnings Report
Achieved financial results consistent with beginning of year projections.
Key Takeaways
Utah Medical Products reported a decrease in revenue and operating income for the second quarter of 2023, but net income and earnings per share increased. The company's balance sheet remained strong with increased cash and investments.
Worldwide sales decreased by 4.2% compared to Q2 2022.
Sales outside the U.S. outperformed domestic sales, with OUS sales increasing by 4.5% and U.S. domestic sales decreasing by 10.4%.
Operating income decreased by 12.5% due to lower gross profit and higher litigation and salary expenses.
Net income increased by 2.3% due to a lower estimated income tax provision rate and fewer diluted shares.
Revenue by Geographic Location
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...